“…Third, they did not present results related to an essential treatment outcome in SUDs that refer to the attrition rate (AR) [53]; also, they did not take into consideration several other secondary outcomes that are robustly associated with relapse in substance use among clinical populations (i.e., negative affectivity, depressive/anxiety and post-traumatic symptoms and avoidance coping strate-fulness", "mindfulness meditation," "MBI," "mindfulness training", "MBSR," "mindfulness-based cognitive therapy," "MBRP," "dialectical behavior therapy," "ACT," "spiritual self-schema therapy," "Vipassana meditation," and "Zen meditation" in combination with the name of each substance (i.e., substances, drugs, alcohol, marijuana, cocaine, opioid, heroin, methamphetamine). The references of reviews and meta-analyses were referred to as additional sources of information [49][50][51][61][62][63].…”